By Anika Milian, Esq., Co-Founding Partner, B&M Law Group, PLLC · November 17, 2026

Short answer: not on the strength of the Hims launch. Hims & Hers has announced a November rollout of its "Peptides+" line, and some owners are reading that as permission to buy vials and keep them in the clinic fridge. The federal policy behind the news does not work that way. Your clinic's lane is the exam, the prescription and the pharmacy paper trail, not inventory.

If you searched "can a medspa stock peptides" or "can my clinic sell peptides now that Hims does," this article is for you.

Can a medspa stock peptides? What the policy actually says

As we describe in our article on the HHS peptide policy, the interim federal policy is enforcement discretion for certain peptides made by 503A compounding pharmacies on a patient-specific prescription.

Let us unpack those terms:

  • Enforcement discretion means a regulator chooses not to prioritize enforcement. It is not an approval, and it does not change the law.
  • 503A pharmacy refers to Section 503A of the federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a). It covers state-licensed pharmacies that compound a medication for an individual patient based on a valid prescription.
  • Patient-specific prescription means a licensed prescriber evaluated a particular person and ordered a drug for that person.

Put together, the policy describes a pharmacy preparing a drug for a named patient after a clinician has examined that patient. It does not describe a clinic buying bulk vials and deciding later who gets them.

What Hims is actually doing

According to AmSpa's November 10 coverage, Hims says its initial Peptides+ offerings will include NAD+, sermorelin and glutathione, and that it plans to offer BPC-157 and TB-500 only "if permitted under evolving federal policy." Please read the primary sources yourself, because product lists and timing can change.

Hims is a telehealth company. It has its own clinicians, pharmacy relationships and shipping model, built so that each order starts with an evaluation and ends with a pharmacy dispensing to a patient. That structure is exactly what the policy contemplates.

A medspa buying vials from a supplier and storing them for walk-ins is a different structure. Hims launching a product does not make your version lawful.

Why the exam is your edge

Peptide demand is moving online. Clients can now order from an app. What an app cannot offer is a hands-on assessment, a clinician who knows the patient's history, and in-person follow-up.

That is your advantage. It is also your legal footing. A prescription tied to a real exam, filled by a licensed pharmacy, with records that connect the two, is the model the policy supports. Inventory without that chain is where clinics get into trouble.

Did anything change in 2026?

Yes. The federal interim policy is new, and the market reacted quickly. But it is interim, so it can be narrowed, extended or replaced. It also applies to specific substances under specific conditions, and Hims' own "if permitted" caveat on BPC-157 and TB-500 shows that some peptides remain uncertain.

Florida law did not change because of the Hims launch. Florida's pharmacy, physician, nursing and drug-distribution rules still apply. Before you add any peptide, confirm the current text of the federal policy and whether each substance is covered.

What your clinic needs to do

  1. Confirm who can prescribe. A Florida-licensed physician, or an advanced practice nurse or physician assistant acting within the scope of their license and supervision or protocol arrangements, must perform the evaluation. See our article on APRN Botox supervision for how supervision issues play out in practice.
  2. Document a real exam. Record history, medications, contraindications, the clinical reason for the peptide and informed consent. A questionnaire alone is a weak record.
  3. Use a licensed pharmacy. Verify the pharmacy's Florida licensure or nonresident permit, its compounding status and its inspection history. Keep copies.
  4. Keep the prescription patient-specific. Each order should name the patient. Avoid "office stock" arrangements unless an attorney has confirmed the source is legally allowed to supply them. Office-use supply generally falls under different federal rules than 503A.
  5. Know the dispensing rules. In Florida, a practitioner who dispenses drugs must meet registration and labeling requirements under section 465.0276, Florida Statutes. Confirm whether your model counts as dispensing.
  6. Check your marketing. Do not describe a peptide as approved, safe or effective for conditions the FDA has not reviewed it for.

Signs your peptide program may be set up the wrong way

  • "We buy vials from an online supplier and keep them ready for clients."
  • "The pharmacy ships to us, and we decide who gets it later."
  • "Our intake is a web form, and the provider signs off in bulk."
  • "The label says 'research use only,' but our clients are fine with that."
  • "We list BPC-157 on our menu because Hims is moving that direction."
  • "We cannot find the pharmacy's license, but they have always delivered."

What can happen if you get it wrong

Using unlawfully sourced or unprescribed drugs can lead to discipline against the clinic's licensed providers under section 456.072, Florida Statutes and the relevant practice acts. Selling or distributing drugs without proper permits can implicate Florida's drug distribution rules, including section 499.01. Federal exposure is possible too.

Beyond regulators, an adverse reaction can lead to a malpractice or product-related claim. If your records do not show an exam, a prescription and a licensed source, your defense and your insurance coverage may both be harder. Confirm your policy's terms with your broker.

How to fix it: a quick checklist

  • Pull every peptide product in your fridge and list its source, label and invoice.
  • Stop offering any product you cannot trace to a licensed pharmacy and a patient-specific prescription.
  • Write a peptide protocol covering exam, indications, consent, follow-up and who may prescribe.
  • Verify each pharmacy's license and keep the file.
  • Update your consent forms and menu language.
  • Train front-desk staff not to quote, promise or book peptides before a provider evaluation.
  • Ask your attorney to review the protocol and your pharmacy agreements.

FAQ

Can a medspa sell peptides in Florida?

Only through a lawful structure, which generally means an evaluation by a licensed prescriber and a prescription filled by a licensed pharmacy for that patient. Buying vials for general stock is a different and riskier model.

Does the HHS policy make peptides legal?

No. It describes enforcement discretion for certain compounding, which is not approval. Confirm the current text and which substances it covers.

Is BPC-157 allowed?

Hims says it will offer BPC-157 only "if permitted under evolving federal policy," which signals uncertainty. Ask your attorney and pharmacy about its current status before offering it.

Can I buy peptides from an online supplier for my clinic?

Be very cautious. If the supplier is not a licensed pharmacy filling a patient-specific prescription, you may be outside the policy.

Can a nurse practitioner order peptides?

Possibly, depending on licensure, scope, supervision and protocol requirements. Confirm your setup before ordering.

Talk to a Florida medspa compliance attorney

B&M Law Group advises medspas and wellness practices throughout Florida, in English and Spanish. Our peptide protocol and pharmacy-sourcing review looks at your prescribing structure, pharmacy agreements, consent forms and marketing. To review your program, book a consultation.


Sources: Hims & Hers newsroom: Expanding safe access to peptides · AmSpa: Hims & Hers plans launch of peptide treatments · 21 U.S.C. 353a · Fla. Stat. 465.0276 · Fla. Stat. 499.01 · Fla. Stat. 456.072